✅ Model Answer:
• Low voltage QRS (reduced amplitude).
• Diffuse non-specific ST-T changes (ST elevation/depression, T wave inversion).
• Sinus tachycardia (most common rhythm).
• Arrhythmias: PVCs, VT, AV block, prolonged PR.
• Pathological Q waves may appear (if necrosis).
❓ Q2. What are the causes of myocarditis in children? How would you classify them?
✅ Model Answer:
• Viral (Coxsackievirus B – most common, adenovirus, parvovirus B19, COVID-19).
• Post-infectious (MIS-C).
• Bacterial (Lyme, diphtheria), autoimmune (SLE, JIA), drug-induced, giant cell, eosinophilic, idiopathic.
❓ Q3. What is the diagnostic workup for suspected myocarditis? What is the role of cardiac MRI?
✅ Model Answer:
• Workup: troponin, BNP, ECG, echo, CXR, viral studies.
• Cardiac MRI: Lake Louise criteria – T2 edema, early gadolinium enhancement, late gadolinium enhancement (subepicardial/midwall – viral myocarditis pattern).
❓ Q4. What is the role of troponin in myocarditis? Is it always elevated?
✅ Model Answer:
• Troponin is a sensitive marker of myocardial injury, elevated in most cases.
• May be normal in mild or early cases.
• Serial troponin monitoring helps track disease course.
❓ Q5. What are the Lake Louise criteria for cardiac MRI in myocarditis? What is the pattern of late gadolinium enhancement in myocarditis?
✅ Model Answer:
• Lake Louise criteria: T2 edema, early gadolinium enhancement, late gadolinium enhancement (≥2 of 3).
• LGE pattern: subepicardial or midwall (non-ischemic), not following coronary territory.
❓ Q6. What are the echocardiographic findings in myocarditis? How does it differ from dilated cardiomyopathy?
✅ Model Answer:
• Echo: LV dysfunction (global or regional), LV dilation, pericardial effusion, MR.
• Myocarditis: acute onset, fever, troponin elevation, patchy WMA, LGE on MRI.
• DCM: chronic, progressive, symmetric dilation, no LGE (or different pattern).
❓ Q7. What is the management of acute myocarditis? What is the role of inotropes and mechanical support?
✅ Model Answer:
• Supportive: diuretics, inotropes (milrinone preferred), avoid digoxin.
• ECMO for fulminant myocarditis (refractory shock).
• IVIG (controversial), corticosteroids for giant cell or MIS-C.
❓ Q8. When is ECMO indicated in myocarditis? What is the prognosis?
✅ Model Answer:
• ECMO: fulminant myocarditis, refractory shock, cardiac arrest.
• Prognosis: 60-80% survival, many recover LV function within weeks.
❓ Q9. What is the role of IVIG in myocarditis? Is it always indicated?
✅ Model Answer:
• IVIG 2 g/kg – may have benefit, evidence is controversial.
• Not always indicated; used in fulminant, MIS-C, or idiopathic cases.
• Side effects: headache, aseptic meningitis, thrombosis.
❓ Q10. What is the role of endomyocardial biopsy in myocarditis? When is it indicated?
✅ Model Answer:
• Gold standard (Dallas criteria) – low sensitivity (patchy inflammation).
• Indications: fulminant myocarditis (rule out giant cell), giant cell/eosinophilic, vasculitis, inconclusive cases.
❓ Q11. What is giant cell myocarditis? How does it differ from lymphocytic myocarditis?